跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Edelfosine
首页
药物
Edelfosine
Edelfosine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PROCESS FOR THE SYNTHESIS OF (S)-EDELFOSINE OR (R)-EDELFOSINE
EP 4424677 A1
申请人: RDP PHARMA AG
优先权: 2023
EP
US
WO
4 件公开
Methods for the treatment and amelioration of atopic dermatitis
US 7998945 B2
申请人: JADO TECHNOLOGIES GMBH
优先权: 2006
US
3 件公开
Edelfosin for the treatment of brain tumors
US 6514519 B1
申请人: MED MARK PHARMA GMBH
优先权: 1998
US
Means and methods for the treatment and prevention of allergic diseases
CN 101355929 A
申请人: JADO TECHNOLOGIES GMBH
优先权: 2005
CN
Anticancer composition containing tyrosine kinase inhibitor
CN 101077334 A
申请人: JINAN KANGQUAN MEDICAL SCIENCE
优先权: 2007
CN
PHOSPHOINOSITIDE MODULATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
US 2008312187 A1
申请人: KIM TAE-WAN
优先权: 2007
US
Thermostatic sustained release injection containing phosphatidylinositol 3-genistein inhibitor and preparing method thereof
CN 101229117 A
申请人: SHANDONG LANJIN PHARMACEUTICAL
优先权: 2007
CN
Sustained-release injection containing octadecyl dimethyl-4-piperidine phosphate
CN 101347409 A
申请人: JINAN JIFU MEDICINE SCIENCE CO
优先权: 2008
CN
Use of edelfosine and other synthetic ether alkyl-lysophospholipids (APLs) for seizures and related diseases
US 9717746 B2
申请人: FERCHMIN PETER ANDREW
优先权: 2014
US
药物
反馈